Analysis updated on Oct. 14, 2026 (UTC) · Alpha · vs marketSwitch to Total · OTC
Our AI ranks Weed, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Weed, Inc. is a small-cap company with a market capitalization of $3M. It ranks number 12 by market capitalization among the 12 Services-Commercial Physical & Biological Research issuers in our coverage with a current forecast.
A per-ticker accuracy statistic for BUDZ is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.3%, buy ≥ +0.5%, sell < -0.5%, strong sell < -1.6% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-13 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, BUDZ included.
Follow BUDZ free90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Services-Commercial Physical & Biological Research peers listed below that report each metric.
| Metric | BUDZ | Rank |
|---|---|---|
| Market Cap | $3M | 12/12 |
| EPS | $0.00 | – |
| Metric | BUDZ | Rank |
|---|---|---|
| ROA | -84.8% | 9/13 |
| ROIC | 44.3% | 2/12 |
| Tax Rate | -0.0% | – |
| Metric | BUDZ | Rank |
|---|---|---|
| Current Ratio | 0.01x | 14/16 |
| Interest Coverage | -673.4x | 11/13 |
| Working Capital | -$1M | 9/15 |
| Metric | BUDZ | Rank |
|---|---|---|
| Operating Cash Flow | -$140K | 7/15 |
| Metric | BUDZ | Rank |
|---|---|---|
| Operating Income | $0.00M | 7/15 |
| Net Income | $0.00M | 5/13 |
| Metric | BUDZ | Rank |
|---|---|---|
| Shares Outstanding | 148M | – |
| Total Current Assets | $10K | 2.0% of assets |
| Cash & Short-term Investments | $0.00M | 0.0% of assets |
| Total Liabilities | $1M | 282.4% of assets |
| Short-term Debt | $1M |
Companies classified under the same SEC industry code as Weed, Inc. (Services-Commercial Physical & Biological Research): 16 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| BUDZ Weed, Inc. | ▲ | $3M |
| IQV Iqvia Holdings Inc. | ▼ | $43.51B |
| INCY Incyte Corp | ▼ | $21.70B |
| MEDP Medpace Holdings, Inc. | ▶ | $17.02B |
| CRL Charles River Laboratories International, Inc. | ▶ | $14.27B |
| ICLR Icon Plc | ▶ | $12.68B |
| ABSI Absci Corp | ▲ | $1.56B |
| OABI Omniab, Inc. | ▲ | $683M |
| NRC Nrc Health | ▲ | $446M |
| MXCT Maxcyte, Inc. | ▲ | $100M |
| ONMD Onemednet Corp | ▶ | $23M |
| VSBC Vitaspring Biomedical Co. Ltd. | ▼ | $7M |
| BIAF Bioaffinity Technologies, Inc. | ▼ | N/A |
| CBIH Cannabis Bioscience International Holdings, Inc. | ▼ | N/A |
| FOXO Foxo Technologies Inc. | ▼ | N/A |
| ISPC Ispecimen Inc. | ▼ | N/A |
TUCSON, Ariz., Dec. 27, 2024 (GLOBE NEWSWIRE) -- via IBN – WEED Inc. (OTCQB: BUDZ), ("WEED," "HEMP" or the "Company"), a global cannabis and hemp bioresearch company based in the U.S., shares the ...
WEED, Inc. controls a portfolio of more than 200 landrace and heritage cannabis strains, including well-known names such as Panama Red®, Acapulco Gold®, Red Bud Colombian, and Santa Marta Gold, Thai ...
Remergify Inc., a leading strategic advisory firm specializing in asset monetization and blockchain integration, to use its expertise in blockchain, tokenization and AI expertise to spearhead the ...
Our AI ranks Weed, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
A per-ticker accuracy statistic for BUDZ is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Weed, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.
16 issuers in our coverage, BUDZ included, share the SEC industry code Services-Commercial Physical & Biological Research. The largest are: Iqvia Holdings Inc. (IQV), Incyte Corp (INCY), Medpace Holdings, Inc. (MEDP), Charles River Laboratories International, Inc. (CRL), Icon Plc (ICLR), Absci Corp (ABSI).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.
Signals, companies, plans: answered from live data.
I read Intratio's daily model signals, company data and your account to answer in seconds, in your language.